Immunogenicity of COVID-19 Vaccine on Heterologous Schedule

Clinical trial NCT05054621 · COMPLETED

Trial details

NCT number: NCT05054621
Sponsor: Chang Gung Memorial Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid-19 Vaccine Immunogenicity Reactogenicity Healthy

Start date: 2021-09-15
Primary completion: 2022-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.